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To the Editor: Cukor et al.1 very recently showed that dialysis
patients were more depressed and had lower adherence to
medication when compared with patients with renal
transplantation. In addition, they found that lack of
adherence to medical treatments is independently associated
with depressive behavior as determined by the Beck
Depression Inventory.
Previously we have observed very similar results in
hemodialysis patients, although our study differs from the
study by Cukor et al. in some methodological aspects.2 We
have shown that among 86 hemodialysis patients who were
on the renal transplantation waiting list, 49 were nonadher-
ent. In our study, clinical nonadherence was defined as
skipping or shortening of dialysis sessions, interdialytic
weight gain of 45.7% of body weight, a predialysis
potassium level of 46mEq/l, and a predialysis phosphorus
level of47.5mg per 100ml. We recorded sociodemographic
and laboratory parameters. We also evaluated quality of life
(by the SF-36) and depressive behavior by the Beck
Depression Inventory. Although nonadherent patients had
lower quality of life, and higher Beck Depression Inventory
scores, nonadherence was associated only with Beck Depres-
sion Inventory scores in our study (odds ratio: 2.146;
confidence interval: 2.052–2.350; P: 0.002).2
Nonadherence in dialysis patients was associated with
increased mortality.3 On the other hand, depression was
considered the most common psychopathology among
dialysis patients.4 In light of Cukor et al.’s and our findings,
we suggest that depression may be one of the permissive
factors for nonadherent behavior in dialysis patients and thus
related with increased mortality. In addition, treatment of
depression may improve adherence. Longitudinal studies are
needed to highlight these issues.
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We thank Drs Afsar and Akman for their letter.1 We are
gratified that our study2 had results similar to their
findings3 even though the populations were quite
different, as this shows the robustness of the relationship
between nonadherence and depression. In further analyses
of our data, we identified social support4 as significantly
associated with medication adherence (r¼ 0.28,
Po0.05) and depression (r¼0.40, Po0.001). In our
exploratory model, depression emerged as a mediator,
suggesting that the relationship between social support
and medication adherence is attenuated through depres-
sive affect.
The scientific study of nonadherence in end-stage
renal disease (ESRD) populations is still in its infancy.
The field lacks a standard assessment strategy or even an
identified minimum threshold of adherence required to
prevent complications. The studies thus far have been
correlational in design; therefore, the direction of the
relationships is undetermined. However, as depression is a
common comorbidity,5 all ESRD patients should be
carefully screened for depression and treatment
regimen adherence. Similarly, interventions to promote
treatment adherence should address the level of depressive
affect. Controlled trials to treat depression in ESRD
are needed, as untreated depression may contribute
directly, or be mediated through nonadherence, to poor
outcomes. These studies should include objective assess-
ments of depression and measure multiple outcomes,
including the effect of psychological therapy on depres-
sion, quality of life, adherence, laboratory values, and
mortality.
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